A new training facility at the Philadelphia Navy Yard wants to put people without a college degree on a path into pharmaceutical manufacturing careers, and its first class of up to 16 students starts in January 2027. The facility, a Kaazi project designed and built by Orchestra Life Sciences, includes a simulated clean room stocked with working lab equipment. Kaazi is a new company that trains the workforce behind the region's booming life-sciences industry.
Emilie Pelletier and Sumit Verma cut the ribbon on the new Kaazi Workforce Training Center at the Navy Yard on Monday, according to WHYY. Kaazi is a new firm launched by Orchestra Life Sciences, a technical consultancy that helps drugmakers set up and run factories that make advanced therapies. Pelletier said the company can help develop the workforce that makes it possible to manufacture medicines in the city.
Orchestra spent close to $2.5 million designing and building the facility, which contains a centrifuge, water bath and environmental monitoring equipment in addition to the simulated clean room. The station's report notes that clean rooms are designed to prevent contamination during manufacturing, and workers inside them wear protective clothing including full-body suits, masks and gloves. During the ribbon-cutting, Lauren Lewitt demonstrated the use of pipettes and a biological safety cabinet for visitors.
Two Tracks, Two Timelines
The first cohort of 12 to 16 students will start training in January, with coursework split by educational background. Some cohorts will require an associate's or bachelor's degree in life sciences and will run four months; others will just need to have taken basic high school and chemistry classes, with those courses stretching to six months. Trainees across both tracks will learn to clean and operate equipment, including environmental monitoring tools, heat sealers and cleaning products.
Verma described the facility as a first-of-a-kind training space unlike any other in the region, according to the same account. He said schools and existing training programs often lack the facilities and instructor expertise needed for advanced therapy manufacturing, leaving a gap that drugmakers needing thousands of specialized workers have struggled to fill. He also said large drugmakers often acquire startups that lack manufacturing capacity and workforce-training systems of their own, which is part of what Kaazi hopes to supply instead.
TerraPower and a Growing Client List
Kaazi's first customers for customized clean-room courses will include TerraPower Isotopes, a nuclear sciences company founded by Bill Gates that is building a $450 million facility in Philadelphia's Bellwether District, per WHYY. That plant will manufacture actinium-225, a rare radioactive isotope being tested as a targeted treatment for cancers including melanoma and certain breast cancers — a prospect Verma said has the industry excited about potential new treatments. TerraPower Isotopes has committed to creating 225 jobs and plans to start production in 2029, after receiving state incentives from Pennsylvania to locate the facility in the city; the state reportedly could not identify existing educational programs offering the specialized training needed to handle radioactive therapies.
Kaazi aims to cater to companies such as Johnson & Johnson, Merck and TerraPower Isotopes, and is now in discussions with Merck and Johnson & Johnson about tailored training programs of its own. The company relocated its headquarters to Philadelphia from Montreal about a year ago. Firms and workers interested in the training programs can contact Kaazi through its website, WHYY reports.
Part of a Broader Regional Push
Kaazi's launch lands amid a wider build-out of no-degree-required pathways into Philadelphia's life-sciences sector. The Wistar Institute and University City District's West Philadelphia Skills Initiative have launched a biomedical technician training program enrolling 18 students in 12 weeks of paid training at Wistar, potentially followed by 10 weeks of hands-on work at Iovance Biotherapeutics in the Navy Yard, according to University City District. That program is designed to lead to a $23-an-hour manufacturing job, and the original Wistar program, running since 2000 with Community College of Philadelphia, has graduated 196 students.
A separate five-organization collaboration created a 22-week paid Biomedical Technician Training Program in aseptic manufacturing, open to applicants with at least a high school equivalency, according to Philadelphia Skills Initiative. That program also leads to a starting pay of $23 an hour for an associate aseptic manufacturing technician role. The Philadelphia region is now home to more than 50 cell and gene therapy companies and attracted $3 billion in sector investment in 2021, with a regional workforce study finding nearly 10,500 people working in related organizations — a 127% jump from a comparable 2020 count.
Across the river, Delaware has tested a similar model. BioConnect DE recognized 24 graduates from its first biomanufacturing training cohort in Wilmington in July 2025, a $3 million, three-year pilot with a 96% graduation rate, according to BioConnect DE. That eight-week, tuition-free program trained participants in Quality Management Systems, current Good Manufacturing Practices, Good Documentation Practices and clean-room procedures, and local employers were reported to be actively considering its graduates for roles in Delaware.
A National Labor Crunch
The push to build degree-free pipelines reflects a labor shortage rippling across American manufacturing. The U.S. will need about 3.8 million new manufacturing employees through 2033, but a skills and applicant gap could leave roughly half of those jobs unfilled, according to PharmaVoice. Many organizations have dropped degree requirements from job listings entirely, hiring instead for skills and technical aptitude, while federal projections point to 12% growth in biochemist and biophysicist jobs between 2025 and 2035 and about 9,400 annual openings for biological technicians. Pharmaceutical manufacturers are also competing for the same workers sought by engineering, defense, semiconductor and energy companies, the outlet notes — a dynamic that has pushed some firms, like Eli Lilly with its $15 million pledge to San Jacinto College, to fund training directly rather than wait for graduates to arrive.
